How to use the speech recognition tool?
NCT02652767
RESCUE
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation.
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2016-04-14
- Closing Date: 2019-04-14
Criteria
Children: No
Adults: Yes
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Neuro-Ophthalmology Rare Diseases (WG2)